Revenue
No reported data
REVELATION BIOSCIENCES, INC. (REVB)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2021
2024
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Research & development | $4.1M | $3.5M | $4.1M | $5.4M | $6.9M | — | — |
| Operating expenses | $9.1M | $8.0M | $8.7M | $10.9M | $12.0M | $145,492 | — |
| Operating income | −$9.1M | −$8.0M | −$8.7M | −$10.9M | −$12.0M | — | — |
| Net income | −$8.9M | −$15.0M | −$120,254 | −$10.8M | −$12.0M | −$1.6M | −$3,638 |
| Basic EPSper diluted share | -$23.95 | -$1,052.16 | -$8.44 | -$149.20 | -$42.50 | -$0.68 | — |
| Diluted EPSper diluted share | -$23.95 | -$1,052.16 | -$8.44 | -$149.20 | -$42.50 | -$0.68 | — |